Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?
Open Access
- 27 May 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 100 (11), 773-783
- https://doi.org/10.1093/jnci/djn148
Abstract
Despite nearly two decades of research investigating the use of dietary antioxidant supplementation during conventional chemotherapy and radiation therapy, controversy remains about the efficacy and safety of this complementary treatment. Several randomized clinical trials have demonstrated that the concurrent administration of antioxidants with chemotherapy or radiation therapy reduces treatment-related side effects. Some data indicate that antioxidants may protect tumor cells as well as healthy cells from oxidative damage generated by radiation therapy and some chemotherapeutic agents. However, other data suggest that antioxidants can protect normal tissues from chemotherapy- or radiation-induced damage without decreasing tumor control. We review some of the data regarding the putative benefits and potential risks of antioxidant supplementation concurrent with cytotoxic therapy. On the basis of our review of the published randomized clinical trials, we conclude that the use of supplemental antioxidants during chemotherapy and radiation therapy should be discouraged because of the possibility of tumor protection and reduced survival.Keywords
This publication has 75 references indexed in Scilit:
- Effect of Amifostine on Response Rates in Locally Advanced Non–Small-Cell Lung Cancer Patients Treated on Randomized Controlled Trials: A Meta-AnalysisInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Randomized Phase II Trial of High-Dose Melatonin and Radiation Therapy for RPA Class 2 Patients With Brain Metastases (RTOG 0119)International Journal of Radiation Oncology*Biology*Physics, 2007
- Effect of vitamin B12, folate, and dietary supplements on breast carcinoma chemotherapy–induced mucositis and neutropeniaCancer, 2004
- Vitamin E Protects DNA from Oxidative Damage in Human Hepatocellular Carcinoma Cell LinesFree Radical Research, 2004
- Antioxidants and Cancer Therapy: A Systematic ReviewJournal of Clinical Oncology, 2004
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Cardioprotection in Patients Undergoing Chemo- and/or Radiotherapy for Neoplastic Disease. A Pilot Study.Japanese Heart Journal, 1996
- Effect of individual and multiple antioxidant vitamins on growth and morphology of human nontumorigenic and tumorigenic parotid acinar cells in cultureNutrition and Cancer, 1996
- A randomised double-blind placebo controlled clinical trial assessing the tolerability and efficacy of glutathione as an adjuvant to escalating doses of cisplatin in the treatment of advanced ovarian cancerEuropean Journal Of Cancer, 1995
- Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancerBritish Journal of Cancer, 1995